We are live on ! Find out more
TS

Thomas Steyer Farallon Capital Management

AUM $21.7B
1-Year Est. Return 79.24%
 

Thomas Steyer founded Farallon Capital Management, a pioneering multi-strategy firm spanning credit, equities, real estate, and event-driven investing. Farallon became known for rigorous research and opportunistic capital allocation across cycles. Although Steyer later focused on public advocacy, the Farallon name remains important in hedge fund history and ongoing 13F tracking.

This Fund
S&P 500
This Quarter Est. Return
+13.12%
1 Year Est. Return
+79.24%
3 Year Est. Return
+204.51%
5 Year Est. Return
+270.91%
10 Year Est. Return
+1,884.18%
AUM
$23.6B
AUM Growth
+$1.71B
Cap. Flow
-$406M
Cap. Flow %
-1.72%
Top 10 Hldgs %
52.37%
Holding
196
New
43
Increased
37
Reduced
38
Closed
21

Top Buys

Rank Stock Value
1
HES
Hess
HES
+$502M
2
UNH icon
UnitedHealth
UNH
+$254M
3
ABNB icon
Airbnb
ABNB
+$243M
4
AON icon
Aon
AON
+$196M
5
SRPT icon
Sarepta Therapeutics
SRPT
+$152M

Top Sells

Rank Stock Value
1
CHTR icon
Charter Communications
CHTR
+$311M
2
TMO icon
Thermo Fisher Scientific
TMO
+$228M
3
BX icon
Blackstone
BX
+$222M
4
TRU icon
TransUnion
TRU
+$203M
5
SPLK
Splunk Inc
SPLK
+$202M

Sector Composition

Rank Sector Weight
1 Healthcare 26.88%
2 Technology 10.2%
3 Financials 8.76%
4 Energy 8.1%
5 Industrials 5.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CNTA
101
DELISTED
Centessa Pharmaceuticals
CNTA
$4.19M 0.02%
+371,000
New +$3.51M
AMLX icon
102
Amylyx Pharmaceuticals
AMLX
$4.31B
$3.27M 0.01%
+1,150,221
New +$15M
IVCP
103
DELISTED
Swiftmerge Acquisition Corp. Class A Ordinary Share
IVCP
$3.25M 0.01%
300,000
– –
COGT icon
104
Cogent Biosciences
COGT
$6.37B
$3.1M 0.01%
462,000
+445,000
+2,618% +$2.75M
PRAX icon
105
Praxis Precision Medicines
PRAX
$10.5B
$3.05M 0.01%
+50,000
New +$2.24M
BACA
106
DELISTED
Berenson Acquisition Corp. I
BACA
$2.96M 0.01%
285,715
– –
AVBP icon
107
ArriVent BioPharma
AVBP
$1.44B
$2.71M 0.01%
+151,768
New +$3.06M
ARYD
108
DELISTED
ARYA Sciences Acquisition Corp IV Class A Odinary Shares
ARYD
$2.25M 0.01%
200,000
– –
MTAL
109
DELISTED
Metals Acquisition
MTAL
$2.02M 0.01%
157,500
– –
MTAL.WS
110
DELISTED
Metals Acquisition Limited Warrants to purchase one share of Ordinary Share, each at an exercise price of $11.50 per share
MTAL.WS
$1.75M 0.01%
825,000
– –
SMC
111
Summit Midstream
SMC
$470M
$1.63M 0.01%
58,214
– –
GATE
112
DELISTED
Marblegate Acquisition Corp. Class A Common Stock
GATE
$1.57M 0.01%
150,000
– –
TVRD
113
Tvardi Therapeutics
TVRD
$24.8M
$1.42M 0.01%
43,229
– –
FBRX icon
114
Forte Biosciences
FBRX
$1.63B
$1.27M 0.01%
72,418
– –
GRND.WS
115
DELISTED
Grindr Inc. Warrants, each exercisable for one share of Common Stock at an exercise price of $11.50 per share
GRND.WS
$1.25M 0.01%
540,000
– –
SLNO
116
DELISTED
Soleno Therapeutics
SLNO
$1.19M 0.01%
27,750
-137,469
-83% -$6.22M
VNET
117
VNET Group
VNET
$1.91B
$1.01M ﹤0.01%
650,000
-1,125,000
-63% -$2.08M
MDGL icon
118
Madrigal Pharmaceuticals
MDGL
$11.9B
$886K ﹤0.01%
3,319
– –
SAGE
119
DELISTED
Sage Therapeutics
SAGE
$802K ﹤0.01%
42,800
– –
LUNRW
120
DELISTED
Intuitive Machines, Inc. Warrants
LUNRW
$772K ﹤0.01%
440,965
-509,035
-54% -$480K
LU icon
121
Lufax Holding
LU
$1.2B
$633K ﹤0.01%
149,999
– –
IOVA icon
122
Iovance Biotherapeutics
IOVA
$3.76B
$385K ﹤0.01%
26,000
-536,000
-95% -$6.24M
BPMC
123
DELISTED
Blueprint Medicines
BPMC
$379K ﹤0.01%
4,000
– –
KRYS icon
124
Krystal Biotech
KRYS
$10.3B
$356K ﹤0.01%
2,000
– –
APLS
125
DELISTED
Apellis Pharmaceuticals
APLS
$353K ﹤0.01%
6,000
– –
3 4
5
6 7

Similar funds

BG
Bahl & Gaynor Cincinnati, Ohio $21.7B AUM 30.58% 1-Year Est. Return
IC
IEQ Capital Foster City, California $21.7B AUM 77.3% 1-Year Est. Return
OSAM
O'Shaughnessy Asset Management Stamford, Connecticut $21.7B AUM 41.93% 1-Year Est. Return
SA
Sanctuary Advisors Indianapolis, Indiana $21.6B AUM 28.31% 1-Year Est. Return
BPA
Beacon Pointe Advisors Newport Beach, California $21.5B AUM 23.65% 1-Year Est. Return
CHP
Castle Hook Partners New York $21.8B AUM 215.45% 1-Year Est. Return
PAG
Private Advisor Group Morristown, New Jersey $21.8B AUM 28.57% 1-Year Est. Return
ETC
Exchange Traded Concepts Oklahoma City, Oklahoma $21.9B AUM 68.6% 1-Year Est. Return

Thomas Steyer's Q1 2024 Portfolio in Review

As of Q1 2024, Thomas Steyer held 196 positions worth $23.6B, up 7.8% from $21.9B the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Thomas Steyer's Q1 2024 filing shows 43 new, 37 increased, 38 reduced and 21 closed positions. Its largest new stake was Airbnb: 1,608,220 shares worth $265M. The largest sale was Charter Communications, an estimated $311M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 27% a quarter earlier, followed by Technology and Financials.

  • Thomas Steyer's largest Q1 2024 buy was Airbnb: 1,608,220 shares worth $265M.
  • Thomas Steyer added most to Hess in Q1 2024, an estimated $502M increase.
  • Thomas Steyer's biggest Q1 2024 reduction was Thermo Fisher Scientific, cutting an estimated $228M.
  • Thomas Steyer fully exited Charter Communications in Q1 2024, selling an estimated $311M.
  • Thomas Steyer's ten largest holdings make up 52% of its $23.6B portfolio in Q1 2024.
  • Thomas Steyer opened 43 new positions and closed 21 in Q1 2024.
  • Thomas Steyer's portfolio value rose 7.8% quarter-over-quarter to $23.6B.

Based on Farallon Capital Management's 13F filing for Q1 2024, filed 15 May 2024.